businessHosted by Dutch Life Sciences / Iventus

The Dutch Life Sciences Conference 2026 connects biotechnology, pharmaceutical and medical technology companies with investors, researchers and entrepreneurs. Its program covers life sciences investment trends, oncology innovation, strategic partnerships, artificial intelligence, neurodegenerative diseases and startup commercialization. The conference features keynote presentations, parallel sessions, startup pitches and networking opportunities.
Date
Time
08:30 AMVenue
Oegstgeest
Netherlands
Hosted By
Dutch Life Sciences / Iventus

Suzanne Spliethoff
Conference Moderator and Presenter

Esther Peters
Director, Leiden Bio Science Park

Felice Verduyn - van Weegen
Partner, EQT Life Sciences
Oegstgeest, Netherlands | Corpus, 1, Willem Einthovenstraat, Leiden Bio Science Park, Oegstgeest, South Holland, Netherlands, 2342 BH, Netherlands

Chrétien Herben
LifeSciences@Work

Dennis Beringer
synTEG Therapeutics

Myron Best
PlateletDx

Else Driehuis
ReFOLD BIO

Katarina Madunic
GlycoDiagnostics

Tezontl Rosario
Autoplan

Mark ter Heide
Gateway Bio

Nettie Buitelaar
Biotech Booster

Jeroen Blokhuis
Oncode Institute

Shobhit Dhawan
Ligase BioPartners

Wigard Kloosterman
CEO, Cyclomics & Tzu Cancer Therapeutics

Ashley van Heteren
Radiogenesis

Peter Ketelaar
LIFE Cooperative

Celine Héchard
Genmab

Arnoud Huisman
CEO, ProteoGuide

Anton Mat
JPP - Life Sciences Marketing & BD

Britta Driessen
BOM (Brabantse Ontwikkelings Maatschappij)

Arunava Ghosh
Progress-Experts in Life Sciences

Daria Kozlova
Deep Breath

Kinga Matula
QurieGen

Carine van den Brink
Axon Lawyers

Gali Artzi
Partner and CTO, PeakBridge
All times are in Europe/Amsterdam.
Participant registration and access to the life sciences exhibition.
Opening remarks, a keynote on life sciences investment trends and the Venture Challenge Spring 2026 presentations and winner announcement.
Opportunity to visit exhibitors and meet conference participants.
Seven early-stage life sciences startups pitch their healthcare innovations to a jury of experts and investors.
Discussion of oncology platforms, radioligand therapies, next-generation immunotherapies, precision medicine and investment opportunities.
Industry experts examine licensing, strategic partnerships, dealmaking and international collaboration in biopharmaceutical development.
Networking lunch and exhibition visits.
Seven later-stage life sciences startups present technologies approaching commercialization and market adoption.
Discussion of practical AI adoption, data security, governance frameworks, platform selection and organizational readiness in life sciences.
Exploration of emerging treatments, clinical research and investment trends in Alzheimer's disease, Parkinson's disease and ALS.
Scheduled break for networking and visiting exhibitors.
Announcement and pitches of the early-stage and later-stage Startup Forum winners, followed by the keynote Eat Less, Need More: GLP-1 and the Rebuilding of the Food System.
Closing drinks, networking and exhibition visits.
Explore other relevant upcoming events.

The 10th edition of the Digi-Tech Pharma & AI 2027 Conference is a leading platform uniting pharmaceutical and technology leaders, healthcare innovators, regulatory authorities and solution...

The largest European event dedicated to orphan drugs and rare diseases. It gathers regulators, pharmaceutical companies, biotech firms, patient organizations, investors, and healthcare prof...

Veeva MedTech Summit Europe brings together medical technology leaders for more than 40 educational sessions across regulatory, quality, clinical, commercial, technology and medical affairs...

The 7th Trinational HealthTech Days connects biotech, medtech and digital health startups with investors, corporates and healthcare innovation leaders from across Europe. The 2026 program c...